Location History:
- Scotland, GB (2008)
- Newhouse, GB (2009 - 2012)
Company Filing History:
Years Active: 2008-2012
Title: Innovations and Contributions of Inventor Robert Gilfillan
Introduction
Robert Gilfillan is a notable inventor based in Newhouse, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on developing compounds that have therapeutic applications in treating various medical conditions.
Latest Patents
One of his latest patents is for an aminoisoquinoline thrombin inhibitor with improved bioavailability. This invention relates to the compound N-(2-oxo-2-propoxyethyl)-β-phenyl-D-phenyl-alanyl-N-[(1-amino-6-iso-quinolinyl)methyl]-L-prolinamide or a pharmaceutically acceptable salt thereof. It also includes a pharmaceutical composition comprising this compound, as well as its use in manufacturing a medicament for treating or preventing thrombin-mediated diseases. Another significant patent involves (pyrido/thieno)-[f]-oxazepine-5-one derivatives. This invention pertains to derivatives having a specific general formula, which are used in the treatment of neurological diseases and psychiatric disorders responsive to enhancement of synaptic responses mediated by AMPA receptors in the central nervous system.
Career Highlights
Throughout his career, Robert Gilfillan has worked with prominent companies such as N.V. Organon and MSD Oss B.V. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Robert has collaborated with notable coworkers, including Simon James Anthony Grove and Julia Adam-Worrall. Their combined efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Robert Gilfillan's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the medical community positively.